Skip to main content

Condition · 0 treatment paths

Retinoblastoma (Pediatric)

Retinoblastoma is a rare cancer of the developing retina in young children, usually under five. It can affect one or both eyes, and some cases are inherited through a gene change.

Severe

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Last updated: How we source & review

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
0Treatment paths
Specialties
3Specialties
Typical severity
SevereTypical severity

About retinoblastoma (pediatric)

What to know

The commonest sign is a white glow in the pupil in photographs, called leukocoria. Others are a squint, a red painful eye or poor vision. Diagnosis uses examination under anaesthetic, ultrasound and MRI, and genetic testing for the RB1 gene. Children with an inherited form need regular eye screening, and siblings may be screened too.

Treatment aims to cure while saving vision where possible. Options include chemotherapy given into an artery of the eye or into the vein, laser, freezing treatment, plaque radiotherapy and injections into the eye. Large tumours may need removal of the eye (enucleation), with chemotherapy afterwards if there are high-risk features. Families travel for specialist ocular oncology centres with intra-arterial chemotherapy.

Pre-flight workup

Tests to have already done

  • Examination under anaesthesia report from a specialist, with fundus drawings or retinal photographs mapping each tumour and any vitreous or subretinal seeding.
  • MRI of the brain and orbits, to look for optic nerve involvement and to exclude pineal tumours.
  • Ultrasound of the eyes and details of the child's age at diagnosis, eye laterality and family history.
  • Genetic test results for the RB1 gene, either in blood or tumour, which affect risk to the other eye and to relatives.
  • Any treatments already given, such as chemotherapy, laser, freezing treatment or eye surgery, with dates.

Second opinion

When to get a second look

  • Your child has been advised to have an eye removed and you want to confirm that saving the eye is not possible.
  • The cancer is in both eyes, or the disease is advanced, which requires a centre with experience of specialised treatment.
  • Treatment has not worked or the tumours have returned.
  • Radiotherapy is being suggested, which carries long-term risks in children with the hereditary form, and you want alternatives reviewed.

Talking to your doctor

Questions to ask

  1. What group or stage is my child's retinoblastoma, and is there any sign it has spread beyond the eye?
  2. Can the eye be saved with chemotherapy given into an artery or the eye, rather than removal?
  3. If the eye must be removed, what will the artificial eye and follow-up involve?
  4. Does my child have the hereditary form, and should siblings and parents be tested?
  5. What are the risks of radiotherapy and what treatments avoid it?
  6. How long will examinations under anaesthetic continue, and what is the risk of second cancers?

Outlook

Realistic prognosis

With early diagnosis and specialist treatment, survival for retinoblastoma confined to the eye is very high, well over 90 percent in well-resourced settings. Outlook worsens if the cancer has spread along the optic nerve or outside the eye. Eye salvage depends on tumour size and stage. Children with the hereditary form need lifelong monitoring for other cancers.

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For retinoblastoma (pediatric), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.

  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.

  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.

  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

04 · FAQ

Common questions about retinoblastoma (pediatric)

Will my child lose the eye?

Not always. Many eyes can be saved with chemotherapy and local treatments such as laser or freezing, especially in early disease. Eye removal is needed for advanced tumours to protect life.

Is retinoblastoma hereditary?

Some children carry an RB1 gene change that can be passed on, particularly when both eyes are affected. Genetic testing guides screening of siblings and future children.

What follow-up is needed?

Frequent eye examinations, often under anaesthesia, continue for years. Children with the hereditary form need long-term awareness of other cancers.

Can my child lead a normal life?

Most children treated successfully do, including those with one eye or an artificial eye. Vision support may be needed if both eyes were affected.

Clinical context

Working up retinoblastoma (pediatric) properly

A condition like retinoblastoma (pediatric) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
How this page is made

Methodology and editorial standards

This retinoblastoma (pediatric) overview is written by the editorial team from published Oncology sources and lists 0 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
  2. Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
  3. Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
  4. Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
  5. Independence. Hospitals cannot pay to change their position on our pages.
Data sources for this page
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Next step · Retinoblastoma (Pediatric)

Free second opinion on your Retinoblastoma case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.